3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Hepatocellular
10
Colorectal Neoplasms
9
Rectal Neoplasms
8
Pancreatic Neoplasms
8
Wilms Tumor
7
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Glioma
7
Sarcoma
6
Rhabdomyosarcoma
6
Rhabdoid Tumor
6
Osteosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Lung Neoplasms
5
Central Nervous System Neoplasms
5
Stomach Neoplasms
4
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Melanoma
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Lymphoma
2
Liver Neoplasms
2
Interventions
pembrolizumab
49
Nivolumab
21
Cisplatin
11
Cetuximab
11
Carboplatin
10
Paclitaxel
8
Gemcitabine
8
Docetaxel
8
atezolizumab
7
Ipilimumab
7
Cyclophosphamide
7
spartalizumab
6
durvalumab
6
Fluorouracil
6
Capecitabine
6
fludarabine
5
avelumab
5
Albumin-Bound Paclitaxel
5
cemiplimab
4
Trastuzumab
4
Taxes
4
Oxaliplatin
4
Leucovorin
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
tremelimumab
3
tisotumab vedotin
3
aldesleukin
3
Specimen Handling
3
Interleukin-2
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
X-Rays
×
Gastrointestinal
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled